Virax Biolabs Group Ltd
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-1.2M | $22.6K |
| FY2021 | — | $-650.7K | $17.6K |
| FY2022 | — | $-974.6K | $21.8K |
| FY2023 | — | $9.1M | $9.4M |
| FY2024 | — | $5.4M | $3.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-1.2M | $22.6K |
| FY2021 | — | $-650.7K | $17.6K |
| FY2022 | — | $-974.6K | $21.8K |
| FY2023 | — | $9.1M | $9.4M |
| FY2024 | — | $5.4M | $3.6M |